All IP Services
All about IP
34, chemin des Colombettes
CH-1211 Geneva 20, Switzerland
Visit Us |
All about WIPO
Query > English > 2019
Looking Good: An Introduction to Industrial Designs for Small and Medium-sized Enterprises
This is the second in a series of guides on "Intellectual Property for Business". It focuses on industrial designs, a key factor in determining the success of products in the market.
Publication year: 2019
WIPO Technology Trends 2019 – Artificial Intelligence
This report is the first in a new series from WIPO tracking the development of technologies through the analysis of data on innovation activities. It reveals trends in patenting of artificial intelligence (AI) innovations, the top players in AI from industry and academia, and the geographical distribution of AI-related patent protection and scientific publications. Its findings are accompanied throughout by commentary and industry perspectives from more than 20 of the world's leading experts in AI, making it of particular interest to business leaders, researchers and policymakers.
Hague Agreement Concerning the International Registration of Industrial Designs
Common Regulations (as in force on January 1, 2019)
The system of international registration of industrial designs is governed by this Agreement. The objectives of the system are two-fold. Firstly, it offers the possibility of obtaining protection for industrial designs in a number of States through a single deposit made with the International Bureau of WIPO. Secondly, by having a single registration with effect in several countries, the subsequent management of the protection obtained is also made much easier.
WIPO IP Facts and Figures 2018
An overview of intellectual property activity based on the latest available year of complete statistics.
WIPO and the Sustainable Development Goals
Innovation driving human progress
The Sustainable Development Goals (SDGs) provide an ambitious roadmap for human progress. This brochure explains how WIPO's work supports the SDGs by enabling innovation for the economic, social and cultural development of all countries.
Report of the Director General to the 2019 WIPO Assemblies
This report is a presentation of the work accomplished by the Organization during the year that has passed since the last meeting of the WIPO Assemblies.
Guidelines to using evidence from research to support policymaking
This Guide elaborates on the best practices in conducting empirical studies in the intellectual property (IP) field. In so doing, it seeks to improve the credibility of studies, enhance transparency about what conclusions can and cannot be drawn from such studies, and encourage responsible use of studies by IP stakeholders.
Urgent Innovation – Policies and Practices for Effective Response to Public Health Crises
Public health crises require urgent innovation, not only in research and development (R&D) but also in the delivery of therapies and diagnostics. What constitutes “urgency” and “innovation” in these contexts? How are priorities and targets determined? Who is best placed to deliver results? This edition of the Global Challenges in Focus series explores themes discussed at a recent Global Challenges Seminar on the policies and practices that facilitate effective responses to global health crises.
Guide to WIPO's services for country code top-level domain registries
This guide presents country code top-level domain (ccTLD) registry operators and national authorities with information on how to resolve third-party domain name disputes in a cost- and time-saving manner. It explains the main policy design features of a successful Alternative Dispute Resolution (ADR) system, and provides information on the WIPO-created Uniform Domain Name Dispute Resolution Policy (UDRP), including the possibility to tailor the UDRP for specific ccTLD requirements.
BVGH Partnership Hub - Mid-Year Report 2019
The consortium's objective is to establish partnerships that facilitate sharing of IP assets to advance the discovery and development of new drugs, vaccines, and diagnostics for NTDs, malaria, and tuberculosis.